BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 28096702)

  • 1. Early Benefits of a Starter Formula Enriched in Prebiotics and Probiotics on the Gut Microbiota of Healthy Infants Born to HIV+ Mothers: A Randomized Double-Blind Controlled Trial.
    Cooper P; Bolton KD; Velaphi S; de Groot N; Emady-Azar S; Pecquet S; Steenhout P
    Clin Med Insights Pediatr; 2016; 10():119-130. PubMed ID: 28096702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446.
    Simeoni U; Berger B; Junick J; Blaut M; Pecquet S; Rezzonico E; Grathwohl D; Sprenger N; Brüssow H; ; Szajewska H; Bartoli JM; Brevaut-Malaty V; Borszewska-Kornacka M; Feleszko W; François P; Gire C; Leclaire M; Maurin JM; Schmidt S; Skórka A; Squizzaro C; Verdot JJ
    Environ Microbiol; 2016 Jul; 18(7):2185-95. PubMed ID: 26626365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Effect of Supplemented Infant Formulae on Intestinal Biomarkers and Microbiota: A Randomized Clinical Trial.
    Castanet M; Costalos C; Haiden N; Hascoet JM; Berger B; Sprenger N; Grathwohl D; Brüssow H; De Groot N; Steenhout P; Pecquet S; Benyacoub J; Picaud JC
    Nutrients; 2020 May; 12(5):. PubMed ID: 32443684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut Functions in C-Section Delivered Babies: A Pilot Study.
    Baglatzi L; Gavrili S; Stamouli K; Zachaki S; Favre L; Pecquet S; Benyacoub J; Costalos C
    Clin Med Insights Pediatr; 2016; 10():11-9. PubMed ID: 26997881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: a randomized clinical trial.
    Radke M; Picaud JC; Loui A; Cambonie G; Faas D; Lafeber HN; de Groot N; Pecquet SS; Steenhout PG; Hascoet JM
    Pediatr Res; 2017 Apr; 81(4):622-631. PubMed ID: 28002391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome.
    Bazanella M; Maier TV; Clavel T; Lagkouvardos I; Lucio M; Maldonado-Gòmez MX; Autran C; Walter J; Bode L; Schmitt-Kopplin P; Haller D
    Am J Clin Nutr; 2017 Nov; 106(5):1274-1286. PubMed ID: 28877893
    [No Abstract]   [Full Text] [Related]  

  • 8. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.
    Estorninos E; Lawenko RB; Palestroque E; Sprenger N; Benyacoub J; Kortman GAM; Boekhorst J; Bettler J; Cercamondi CI; Berger B
    Am J Clin Nutr; 2022 Jan; 115(1):142-153. PubMed ID: 34617558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial.
    Holscher HD; Czerkies LA; Cekola P; Litov R; Benbow M; Santema S; Alexander DD; Perez V; Sun S; Saavedra JM; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):106S-17S. PubMed ID: 22237870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants.
    Moro G; Minoli I; Mosca M; Fanaro S; Jelinek J; Stahl B; Boehm G
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):291-5. PubMed ID: 11964956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.
    Alliet P; Vandenplas Y; Roggero P; Jespers SNJ; Peeters S; Stalens JP; Kortman GAM; Amico M; Berger B; Sprenger N; Cercamondi CI; Corsello G
    Nutr J; 2022 Feb; 21(1):11. PubMed ID: 35193609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of formula composition on the development of infant gut microbiota.
    Hascoët JM; Hubert C; Rochat F; Legagneur H; Gaga S; Emady-Azar S; Steenhout PG
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):756-62. PubMed ID: 21593648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Bifidobacterium lactis on the growth of infants: a pooled analysis of randomized controlled studies.
    Steenhout PG; Rochat F; Hager C
    Ann Nutr Metab; 2009; 55(4):334-40. PubMed ID: 19844090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synbiotic Effect of
    Marsaux B; Van den Abbeele P; Ghyselinck J; Prioult G; Marzorati M; Bogićević B
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of infant and follow-on formulas containing B lactis and galacto- and fructo-oligosaccharides on infection in healthy term infants.
    Bocquet A; Lachambre E; Kempf C; Beck L
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):180-7. PubMed ID: 23880625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Gut Colonization With Lactobacilli and Staphylococcus in Infants: The Hygiene Hypothesis Extended.
    Salminen S; Endo A; Isolauri E; Scalabrin D
    J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):80-6. PubMed ID: 26230902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two probiotic strains of bifidobacteria in premature infants.
    Underwood MA; Kalanetra KM; Bokulich NA; Lewis ZT; Mirmiran M; Tancredi DJ; Mills DA
    J Pediatr; 2013 Dec; 163(6):1585-1591.e9. PubMed ID: 23993139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk.
    Euler AR; Mitchell DK; Kline R; Pickering LK
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):157-64. PubMed ID: 15699689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial.
    Closa-Monasterolo R; Gispert-Llaurado M; Luque V; Ferre N; Rubio-Torrents C; Zaragoza-Jordana M; Escribano J
    Clin Nutr; 2013 Dec; 32(6):918-27. PubMed ID: 23498848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial.
    Holscher HD; Faust KL; Czerkies LA; Litov R; Ziegler EE; Lessin H; Hatch T; Sun S; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):95S-105S. PubMed ID: 22237884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.